The Path to Commercialization

Industrial Biotech Seeks the Right Policy Framework in Europe Industrial biotechnology is gaining momentum in Europe in its march toward commercialization, say senior executives from companies including DSM and DuPont, who participated in the annual European Forum for Industrial Biotech (EFIB), held recently in Edinburgh. There was a “buzz” around this year’s forum that has not been there before, says Ian Hudson, DuPont president for the EMEA region. Participant numbers at the event exceeded 300, up significantly compared with the year before...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers